THIS common ingredient found in foods and supplements is linked to Blood Cancer
A concerning study reveals that taurine, a common amino acid found in food and supplements, may fuel the growth of leukemia cells. Researchers at the University of Rochester's Wilmot Cancer Institute discovered that leukemia cells readily absorb taurine, promoting glycolysis and cancer progression.
Global cancer cases are predicted to rise by 35 million in 2050, which is a 77% increase from the estimated 20 million cases in 2022, according to the World Health Organization (WHO).
Amid this alarming projection, new research has revealed an unsuspected driver behind one of the most aggressive forms of cancer. The study found that an amino acid, found commonly in the food we eat, and supplements we take, could cause
leukemia
, one of the most aggressive forms of
blood cancer
.
A recent
study
by researchers at the University of Rochester's Wilmot Cancer Institute has found that taurine, which is made naturally in the body and consumed through some foods, is a key regulator of myeloid cancers such as leukemia.
The study is published in the journal Nature. In the preclinical research, the scientists were able to block the growth of leukemia in mouse models and in human leukemia cell samples by using genetic tools to prevent taurine from entering cancer cells.
'We are very excited about these studies because they demonstrate that targeting uptake by myeloid leukemia cells may be a possible new avenue for treatment of these aggressive diseases,' Jeevisha Bajaj, PhD, lead researcher and an assistant professor in the Department of Biomedical Genetics and a member of Wilmot's Cancer Microenvironment research program said in a statement.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Trading CFD dengan Teknologi dan Kecepatan Lebih Baik
IC Markets
Mendaftar
Undo
King Charles' Cancer Secret REVEALED | Royal Whisper EXPOSES Private Health Bombshell | WATCH
They also found that leukemia cells drink up taurine, which promotes glycolysis (a breakdown of glucose to produce energy) to feed cancer growth. Previous researchers have never looked at the cancer-promoting role of taurine. Leukemia has several subtypes, and the survival rates vary. This study found that taurine transporter expression is essential for the growth of multiple subtypes, including acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and myelodysplastic syndromes (MDS), which all originate from blood stem cells in the bone marrow.
Taurine is a non-essential amino acid found naturally in the bone marrow and also in the brain, heart, and muscles. Foods such as meats, fish, and eggs also contain taurine. It is also a key ingredient in some energy drinks and protein powders, and has been used by cancer patients anecdotally.
'Dr. Bajaj's work shows that local levels of taurine in bone marrow may enhance leukemia growth, suggesting caution in use of high-dose taurine supplementation,' Jane Liesveld, MD, a Wilmot oncologist who treats leukemia patients, said.
She also noted that scientists still have a lot to learn about how leukemia cells are reprogrammed and draw energy to thrive and resist treatments.
'Metabolic reprogramming is a hallmark of cancer, and we are at the very beginning of understanding metabolic effects on leukemia cells. The prior focus has been on genetic changes, but the focus is expanding to understanding how leukemia cells are able to hijack various metabolic pathways for their own survival,' she added.
In conclusion, the Wilmot team states in its Nature paper: 'Since taurine is a common ingredient in energy drinks and is often provided as a supplement to mitigate the side effects of chemotherapy, our work suggests that it may be of interest to carefully consider the benefits of supplemental taurine in leukemia patients.'
The researcher noted that future studies are required to investigate levels of taurine in people with leukemia. 'Our current data suggest that it would be helpful to develop stable and effective ways to block taurine from entering leukemia cells,' she said.
One step to a healthier you—join Times Health+ Yoga and feel the change
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India.com
a day ago
- India.com
Acute Myeloid Leukemia: Expert Explains Why This Aggressive Blood Cancer Is Rising Fast In India
AML Awareness Month is marked each June. In India, where infectious diseases dominate public health narratives, a quieter and deadlier crisis is unfolding- Acute Myeloid Leukemia (AML). About 10-15% of all leukaemia cases, AML is a rapidly progressing blood cancer that requires immediate intensive treatment. Yet, delayed diagnosis and poor access to specialised care are making outcomes grim for hundreds of Indians each year. Who is at Risk? Dr Ashay Karpe, Consultant Haematologist and Bone Marrow Transplant Physician, SUNACT Cancer Institute, Mumbai, says, "AML is a cancer of blood and bone marrow that advances quickly, leading to an overproduction of immature white blood cells. While globally it is often diagnosed in the elderly, Indian patients tend to be younger, with many cases presenting in people in their 30s and 40s." According to data from the National Cancer Registry Programme (NCRP), the incidence of AML in India is estimated to be between 0.8 and 5 per 100,000 population. Where and Why Does Diagnosis Lag? In the early stages, AML is a master of disguise. Persistent tiredness, low-grade fever, or frequent bruising are often brushed off as minor or seasonal issues by patients and frontline doctors alike. This tendency, particularly in smaller towns and rural belts, allows the disease to progress unchecked. "AML doesn't give you much time," says Dr Ashay. "By the time a patient sees a specialist, they have often already lost critical ground. Early intervention is the difference between life and loss.' Unfortunately, the early intervention depends on access, and access is so far from equitable. From Chemo to Targeted Therapy Standard AML Therapy isn't just intensive- it's expensive. But the treatment landscape is evolving. Recent advancements in AML treatment like Venetoclax and targeted therapies such as Ivosidenib, are helping clinicians treat patients more effectively, especially those with specific genetic mutations. The arrival of Ivosidenib brings a ray of hope for those with the IDH1 mutation. These drugs are changing the paradigm of AML care, offering new hope where conventional therapy might fail or be too risky for elderly or frail patients. What can change the Odds? Dr Karpe, a leading haematologist, warns: 'In India, without expert guidance at diagnosis, we are already several steps behind global standards. Early bone marrow biopsy and cytogenetic profiling are not luxuries-they are lifesavers.' He underscores that proper counselling and early referral improve survival by allowing timely intensive chemotherapy and transplant planning. 'Patients arrive late, often battling infections for organ failure, says Dr Karpe. In AML, that delay is often irreversible.' Dr Karpe highlights the need to focus on basic upgrades: 1. Training general practitioners to spot danger signs early 2. Ensuring bone marrow testing facilities in public hospitals 3. Including newer targeted drugs and diagnostics as part of the national care He adds, 'A simple CBC (Complete Blood Count) can be the first clue, but someone has to ask for it at the right time. This is why it matters Now." AML might not affect millions, but every case is a race against the clock. In a nation with a rapidly shifting disease landscape, early diagnosis, fast-track specialist care, and policy-level intervention could stop this disease from becoming a death sentence. India has tools. What it needs now is urgency.
Time of India
3 days ago
- Time of India
Princess of Wales shares why she missed Royal Ascot, citing ongoing recovery; Here's what she revealed
Princess Catherine, the Princess of Wales, did not attend Royal Ascot. She cited health concerns. She is focusing on her recovery. Instead, she highlighted Children's Hospice Week. She praised the work of East Anglia's Children's Hospices and Tŷ Hafan Children's Hospice. She had earlier announced her cancer remission. Her absence from Ascot raised concerns. Catherine, Princess of Wales, withdrew from Royal Ascot just 20 minutes before the event due to health concerns. She is balancing her recovery with public duties. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Popular in International 1. Royal insiders hint Kate Middleton may never fully recover — but a bold new chapter with Prince William looms The Princess of Wales , Catherine, has issued her first public statement after unexpectedly withdrawing from Royal Ascot . The 43-year-old was registered to ride in the second carriage alongside King Charles, Queen Camilla, and Prince William. However, she pulled out just 20 minutes before showtime, citing health concerns and the need to balance her recovery with public than comment on her absence from Ascot, Kate used the occasion to draw attention to Children's Hospice Week. As patron of East Anglia's Children's Hospices and Tŷ Hafan Children's Hospice in South Wales, she praised their said, 'No parent expects to hear that their child has a serious health condition… thousands are left heartbroken, fearful of the future and often desperately isolated.''Being able to access the support of one of the UK's 54 children's hospices means they don't have to face that future alone.'Kate returned to the public eye recently and attended Trooping the Colour and the Order of the Garter . She publicly announced her cancer remission in January after undergoing late withdrawal from Ascot came amid concerns about her overall energy levels. Palace insiders confirmed she was 'disappointed' but that fatigue played a key role. The abrupt cancellation caused temporary concern among aides before they clarified it was to protect her ongoing with the couple say she's learning to 'listen to her body' and carve out a sustainable balance between health and royal staff reportedly experienced a momentary 'panic' after her sudden absence. However, King Charles and Prince William supported her decision, prioritising health over royal reaction has been largely supportive. Commentators praised her thoughtful redirection of focus toward high-need charities during a time when public expectation had centred on her presence at Ascot.
Time of India
4 days ago
- Time of India
Cancer fighter voted; why didn't you, Ludh West?
Ludhiana: A 68-year-old Veena Sood of Rishi Nagar, a former banker who is fighting chronic myeloid leukaemia (CML), a bone marrow and blood-related cancer, for the last thirty years, was among the first few voters at Polytechnic College polling booth in the company of her husband, Vinod Sood, who also retired from a bank. Veena Sood has been exercising her right to vote for 40-odd years now and both her husband and she are happy to vote. She claimed to have voted for a candidate she thinks will take care of development needs of the seat.
